Playback speed
10 seconds
ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measurements and Tumor Gene Expression Tests in Hormone-Sensitive EBC
By
ASCO 2022 Conference Coverage
FEATURING
Robert Stein
By
ASCO 2022 Conference Coverage
FEATURING
Robert Stein
0 views
June 7, 2022
Comments 0
Login to view comments.
Click here to Login